Antihistamine Medications: Complete Classification
Antihistamines are divided into two main generations—first-generation and second-generation H1 antihistamines—plus H2 antihistamines that target different receptors, with second-generation agents strongly preferred for allergic conditions due to superior safety profiles. 1
First-Generation H1 Antihistamines
These older agents cross the blood-brain barrier extensively, causing significant sedation and anticholinergic effects that limit their utility in modern practice. 1
Specific agents include:
- Diphenhydramine - causes marked sedation and performance impairment 1
- Hydroxyzine - associated with drowsiness and impaired driving performance that worsens with cellular phone use 1
- Clemastine - produces sedative effects in many patients 1
- Chlorpheniramine - causes sedation and anticholinergic effects 2
- Brompheniramine - has anticholinergic (drying) and sedative effects 3, 2
Critical safety concerns: First-generation antihistamines impair performance even when patients deny feeling drowsy, increase fatal automobile accident risk by 1.5-fold, cause occupational accidents, impair learning in children, and should be avoided in children under 6 years and older adults. 1, 4
Second-Generation H1 Antihistamines
These agents have minimal blood-brain barrier penetration, providing effective symptom relief with dramatically reduced sedation and anticholinergic effects. 1
Non-sedating agents (at recommended doses):
- Fexofenadine - maintains non-sedating properties even at higher than FDA-approved doses, making it truly non-sedating 4, 5
- Loratadine - non-sedating at recommended doses but may cause sedation if exceeded 4
- Desloratadine - non-sedating at recommended doses but may cause sedation at higher doses 4
- Bilastine - considered truly non-sedating, similar to fexofenadine 5
Minimally sedating agents:
- Cetirizine - may cause mild drowsiness in 13.7% of patients (versus 6.3% placebo), has rapid onset of action and is available generically 1, 4
- Levocetirizine - the active enantiomer of cetirizine with similar efficacy profile 4
Key advantages: Second-generation antihistamines have longer duration of action, similar onset to first-generation agents (30 minutes), but peak plasma concentrations occur at 60-120 minutes with maximal tissue effect requiring an additional 60-90 minutes. 1
Intranasal Antihistamines
Azelastine - may cause sedation at recommended doses, offers rapid onset and increased effectiveness over oral antihistamines for nasal congestion, but has poor taste and higher cost. 1, 4
H2 Antihistamines
These target H2 receptors primarily in the gastrointestinal tract with limited vascular smooth muscle distribution. 1
Clinical role: H2 antihistamines are sometimes used concurrently with H1 antihistamines for anaphylaxis, though rigorous supporting evidence is lacking and they play only a minor role in allergic pathophysiology. 1
Clinical Selection Algorithm
For allergic rhinitis: Choose second-generation agents as first-line therapy, with fexofenadine offering the best balance of effectiveness and complete non-sedation across all doses. 4, 6
For patients requiring maximum potency: Cetirizine is the most potent antihistamine available and can be dose-titrated for severe symptoms unresponsive to other agents. 6
For older adults or those at high impairment risk: Fexofenadine is particularly advantageous due to its truly non-sedating properties. 4
For anaphylaxis: Antihistamines serve only as adjunctive therapy after epinephrine administration—they relieve cutaneous symptoms (pruritus, flushing, urticaria) but do not treat cardiovascular or respiratory symptoms and should never replace or delay epinephrine. 1
Critical Pitfalls to Avoid
Never use first-generation antihistamines as first-line therapy for allergic rhinitis given their significant sedation, performance impairment, and anticholinergic effects. 1, 4
Do not assume all second-generation antihistamines have identical sedation profiles—important differences exist, particularly between fexofenadine/loratadine/desloratadine versus cetirizine. 4
Avoid combining first-generation antihistamines at bedtime with second-generation agents in the morning—first-generation agents dosed at bedtime still cause significant daytime drowsiness and performance impairment due to prolonged plasma half-lives. 1
Be cautious with standard doses of loratadine or desloratadine in low body mass patients who may experience sedation due to higher relative dosing. 4